SCPH

scPharmaceuticals
SCPH

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$296.31M
EV
$307.66M
Shares Outstanding
54.00M
Beta
0.39

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$16.33
P/E 2025E
-
P/Revenue 2025E
4.07x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About scPharmaceuticals Inc.

gainify
SCPH

scPharmaceuticals Inc.

SCPH

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. Its lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for ...

Sector

Healthcare

Industry

Biotechnology

CEO

Tucker, John

Employees

163

IPO Date

2017-11-17

Headquarters

25 Mall Road, Suite 203, Burlington, Massachusetts, 01803, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.